4th Quarter - Report
PARRY, ROMANI, DECONCINI & SYMMS for ROCK & ASSOCIATES
Client
Income
$18,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Budget/Appropriations BUD
Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Pharmacy PHA
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.